SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,000 | -59.9% | 11,956 | -2.6% | 0.02% | -82.8% |
| Q2 2021 | $147,000 | -16.9% | 12,271 | -1.7% | 0.13% | +139.3% |
| Q2 2018 | $177,000 | -62.6% | 12,486 | -49.9% | 0.06% | -51.3% |
| Q1 2018 | $473,000 | -54.3% | 24,911 | -60.5% | 0.12% | -62.0% |
| Q4 2017 | $1,034,000 | +394.7% | 63,075 | +353.8% | 0.30% | +413.6% |
| Q3 2017 | $209,000 | +65.9% | 13,900 | -2.8% | 0.06% | +34.1% |
| Q2 2017 | $126,000 | – | 14,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |